Lilly and MiNA Therapeutics announce saRNA research collaboration
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](/images/logo/lilly.png)
Vaccination with Sputnik V launched in India
- Details
- Category: Business
![Russian Direct Investment Fund (RDIF) Russian Direct Investment Fund (RDIF)](/images/logo/rdif.png)
Sputnik V has become the first foreign-made vaccine that is used in India contributing to the world’s largest COVID-19 vaccination campaign.
Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrates high immunogenicity against virus variants in preclinical study
- Details
- Category: Business
![CureVac CureVac](/images/logo/curevac.png)
Novavax Announces positive preclinical data for combination influenza and COVID-19 vaccine candidate
- Details
- Category: Business
![Novavax, Inc. Novavax, Inc.](/images/logo/novavax.png)
Pfizer and BioNTech to provide COVID-19 caccine doses for olympic athletes at the 2020 Tokyo Games
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](/images/logo/lilly.png)
Moderna announces emergency use listing granted by the World Health Organization for its COVID-19 vaccine
- Details
- Category: Business
![Moderna, Inc. Moderna, Inc.](/images/logo/moderna.png)
More Pharma News ...
- Novartis signs initial agreement to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient for Roche's Actemra/RoActemra®
- Moderna announces additional investments to increase global supply for COVID-19 vaccine to up to 3 billion doses in 2022
- Pfizer acquires Amplyx Pharmaceuticals
- Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands
- CureVac Swiss AG initiates rolling submission process for mRNA-based COVID-19 vaccine candidate, CVnCoV, with Swissmedic
- Valneva switches focus to bilateral discussions to supply its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001
- Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY®